JumpStart invests in Milo Biotechnology
Client(s) JumpStart Inc.
Jones Day advised JumpStart Inc. in connection with its investment in Milo Biotechnology LLC, a company developing a therapy for muscular dystrophy patients.
Client(s) JumpStart Inc.
Jones Day advised JumpStart Inc. in connection with its investment in Milo Biotechnology LLC, a company developing a therapy for muscular dystrophy patients.